Zura Bio Limited (ZURA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ZURA Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Zura Bio Limited manages assets, liabilities, and equity through different cycles.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent205.13
Cash & Short-term Investments205.00
Prepaid Expense And Other Assets Current5.37
Total Current Assets210.50
Equipment/Property/Plant Net0.15
Other Assets, Noncurrent2.75
Total Assets213.40
Liabilities
Accounts Payable and Accrued Liabilities, Current LI16.32
Accrued Liabilities, Current2.70
Taxes Payable2.67
Total Current Liabilities16.32
Total Long-term Debt0.00
Total Liabilities16.32
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock472.15
Retained Earnings / Accumulated Deficit-275.07
Other Equity0.00
Common Stockholder's Equity197.09
Non-controlling interests & other0.00
Total Stockholder's Equity197.09
Liabilities & Stockholder's Equity213.40
4 historic quarters locked

Sign in to unlock the full Zura Bio Limited balance sheet history.

About Zura Bio Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001855644-26-000006

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.